BULKY DOCUMENTS
`
`(Exceeds 100 pages)
`
`.
`
`Filed:
`
`208 2012
`
`I
`
`Title: PETITIONER’S NOTICE OF RELIANCE AND
`
`EXHIBITS A THROUGH P.
`
`Par:
`
`lof 1
`
`
`
`
`
`(Exceeds 100 pages)
`
`.
`
`Filed:
`
`208 2012
`
`I
`
`Title: PETITIONER’S NOTICE OF RELIANCE AND
`
`EXHIBITS A THROUGH P.
`
`Par:
`
`lof 1
`
`
`
`
`
`Inthe matterofTrademarkRegistrationNo. 792,115
`
`For the Mark “ASPERGUM”
`
`Jeffrey Kaplan
`
`v.
`
`Petitioner,
`
`Insight Pharmaceuticals L.L.C.
`
`Registrant
`
`United States Patent and Trademark Oflice
`Trademark Trial and Appeal Board
`POB 1451
`
`Alexandria, VA 22313
`
`Dear Commissioner:
`
`Cancellation No: 92053030’
`
`0
`
`Feb. 6”‘ 2012
`
`«
`
`' J
`
`7 2 22/3 3 2 “L l
`
`We are submitting herewith for the record the enclosed documents:
`
`(a) Petitioner’s Notice of Reliance with attached E_xhibits A through P.
`
`(b) Declaration ofJeffrey Kaplan In Support ofPetitioner’s Trial Briefwith attached
`Exhibits A through P.
`
`Thank you
`‘<'.l'9\'l-
`Jeffrey Kaplan, etitioner
`POB 1 1 106
`
`Ft Lauderdale, Fl. 33339
`
`CERTIFICATE OF MAILING
`
`It is hereby certified that this document is being deposited First Class Postage Prepaid with
`the U.S. Postal Service addressed to Baker, Donelson, Bearman, Caldwell & Berkowitz,P.C.
`Att:Mr. Samuel Miller, Esq.- 211 Commerce Street # 800 Nashville, TN 37201.
`
`|llllllIllllllllllllllllllllllllllllllllllHllllll
`02-08-2012
`
`'._1
`
`Patent
`
`3, Tltllfcxlll M-all ?v:Fl- 95
`
`$73
`
`plan
`
`< J
`
`effre
`
`
`
`IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`BEFORE THE TRADEMARK TRIAL AND APPEAL BOARD
`
`In the matter of Trademark Registration No. 792,1 15
`For the Mark “ASPERGUM”
`
`Cancellation No: 92053030
`
`Jeffrey Kaplan
`
`v.
`
`Petitioner,
`
`Insight Pharmaceuticals LLC
`
`Registrant
`
`/
`
`PETITIONER’S NOTICE OF RELIANCE
`
`1. Pursuant to 37 CFR 2.l20(j)(5), Petitioner Jefl'rey Kaplan (“Kaplan”) hereby
`
`introduces into evidence Registrant’s Insight Pharmaceutical LLC (“Insight”) First Set of
`
`Written Interrogatories to Registrant and Responses Thereto, dated March 24"’ 201 1. The
`
`document is relevant on the issues of abandonment with no intent to resume use and specifically
`
`shows Prima Facie evidence that Insight has abandoned the ASPERGUM® trademark with no
`
`plans to resume use. A copy is hereby attached as Exhibit B.
`
`2. Pursuant to 37 CFR 2.120(j)(3)(i), Petitioner Jeffrey Kaplan (“Kaplan”) hereby
`
`introduces into evidence Registrant’s Insight Pharmaceutical LLC (“Insight”) First Set of
`
`ofRequests For Production ofDocuments and Things to Registrant and Responses Thereto,
`
`dated March 24"‘ 2011. The document is relevant on the issues of abandonment with no intent to
`
`resume use and specifically shows Prima Facie evidence that Insight has abandoned the
`
`ASPERGUM® trademark with no plans to resume use. A copy is hereby attached as Exhibit C.
`
`
`
`3. Pursuant to 37 CFR 2.120(i)(5), Petitioner Jeflrey Kaplan (“Kaplan”) hereby
`
`introduces into evidence Registrant’s Insight Pharmaceutical LLC (“Insight”) First Set of of
`
`Requests For Admissions to Registrant and Responses Thereto, dated March 22nd 2011. The
`
`document is relevant on the issues of abandonment with no intent to resume use and specifically
`
`shows Prima Facie evidence that Insight has abandoned the ASPERGUM® trademark with no
`
`plans to resume use. A copy is hereby attached as Exhibit D.
`
`4. Pursuant to 37 CFR 2.l22(d)(2) Kaplan hereby introduces into evidence Federal
`
`Trademark Registration his title copies for the marks Puss’ N Boots® Reg. No.4,089,070
`
`for cat Food, Tegrin® Reg. No. 4,081,335 for medicated shampoo, Hai Karate® Reg. No.
`
`4,010,208 for afiershave cologne, Hai Karate Afier Shave ® Reg. No. 4044298 for T-Shirts,
`
`Chipwich® Serial No. 85421384 for T-Shirts; Di-GeI® Reg. No. 4,029,805 for antacids,
`
`Chipwich® Reg. No. 4,062,133 for Ice Cream, Datril® Reg. No.4010296 for analgesics, Mavi
`
`Power® Reg. No. 3,871,053 for energy drinks containing mavi extract, Tepache Power® Reg.
`
`No. 3,854,453 for energy drinks containing tepache extract, Mr. Q. Sparkling Gin® Reg. No.
`
`3,891,044 for spirits, Mr. Q. Cumber® Reg. No. 3,849,496 for non-alcoholic beverage and
`
`Sparkling Cow® Reg. No. 3,800,225 for non- alcoholic beverages namely carbonated beverage.
`
`The documents are relevant on the issues regarding Kaplan’s Standing and Bona Fide Intent to
`
`Use the mark ASPERGUM when he filed his ITU Trademark Application. A copy is hereby
`
`attached as Exhibit A.
`
`5. Pursuant to 37 CFR 2.l22(b) and 37 CFR 2.l22(e) Kaplan hereby introduces into
`
`evidence Kaplan’s partial file history for the application to register ASPERGUM for medicated
`
`chewing gum, Serial No. 85126700 which was refused registration under Trademark Act
`
`Section 2(d), 15 U.S.C. Section l052(d) based on likelihood of confusion with Insight’s involved
`
`registration.
`
`
`
`The documents are relevant on the issues regarding Kaplan’s Standing to Use the mark
`
`ASPERGUM when he filed his ITU Trademark Application. A copy is hereby attached as
`
`Exhibit 0
`
`6. Pursuant to TBMP 704.08(b) and 37 CFR § 2.122(e). regarding downloaded and
`
`printed intemet materials Kaplan hereby introduces into evidence Insight’s official web page at
`
`www.insightpharma.com dated December 14"‘ 2010. The document is relevant on the issues of
`
`abandonment with no intent to resume use and specifically shows Prima Facie evidence that
`
`Insight has abandoned the ASPERGUM® trademark with no plans to resume use. No mention
`
`of the product ASPERGUM® is present on the Insight web page nor any mention of a future re-
`
`launch of ASPERGUM® is present on the web page. A copy is hereby attached as Exhibit E.
`
`7. Pursuant to TBMP 704.08(b) and 37 CFR § 2.122(e). regarding downloaded and
`
`printed intemet materials Kaplan hereby introduces into evidence an email between Kaplan and
`
`Insight dated September 9"‘ 2010. The document is relevant on the issues of abandonment with
`
`no intent to resume use and specifically shows Prima Facie evidence that Insight has abandoned
`
`the ASPERGUM® trademark with no plans to resume use. A copy is hereby attached as Exhibit
`
`F.
`
`8. Pursuant to TBMP 704.08(b) and 37 CFR § 2.122(e). regarding downloaded and
`
`printed intemet materials Kaplan hereby introduces into evidence a web blog entitled Aspergum,
`
`Where to Buy dated December 14th 2010. The document is relevant on the issues of
`
`abandonment with no intent to resume use and specifically shows Prima Facie evidence that
`
`Insight has abandoned the ASPERGUM® trademark with no plans to resume use. A copy is
`
`hereby attached as Exhibit G.
`
`
`
`9. Pursuant to TBMP 704.08(b) and 37 CFR § 2.122(e). regarding downloaded and
`
`printed intemet materials Kaplan hereby introduces into evidence a Wikipedia Article dated
`
`December 1“ 2010. The document is relevant on the issues of abandonment with no intent to
`
`resume use and specifically shows Prima Facie evidence that Insight has abandoned the
`
`ASPERGUM® trademark with no plans to resume use. A copy is hereby attached as Exhibit
`
`H.
`
`10. Pursuant to TBMP 704.08(b) and 37 CFR § 2.122(e). regarding downloaded and
`
`printed intemet materials Kaplan hereby introduces into evidence an intemet blog article dated
`
`February 17"‘ 2011. The document is relevant on the issues of abandonment with no intent to
`
`resume use and specifically shows Prima Facie evidence that Insight has abandoned the
`
`ASPERGUM® trademark with no plans to resume use. A copy is hereby attached as Exhibit
`
`1.
`
`1 1. Pursuant to 37 CFR 2.120(i)(3)(i), Petitioner Jeffrey Kaplan (“Kaplan”) hereby
`
`introduces into evidence Registrant’s Insight Pharmaceutical LLC (“Insight”) First Set of
`
`of Requests For Production of Documents and Things to Registrant and Responses Thereto,
`
`dated March 24"‘ 2011 specifically Sales and Refunds of ASPERGUM® products for the year
`
`2005. The document is relevant on the issues of abandonment with no intent to resume use and
`
`specifically shows Prima Facie evidence that Insight has abandoned the ASPERGUM®
`
`trademark with no plans to resume use. A copy is hereby attached as Exhibit J.
`
`12. Pursuant to 37 CFR 2.120(i)(3)(i), Petitioner Jeffrey Kaplan (“Kaplan”) hereby
`
`introduces into evidence Registrant’s Insight Pharmaceutical LLC (“Insight”) First Set of
`
`of Requests For Production of Documents and Things to Registrant and Responses Thereto,
`
`dated March 24"‘ 2011 specifically Sales and Refunds ofASPERGUM® products for the year
`
`2006.
`
`
`
`The document is relevant on the issues of abandonment with no intent to resume use and
`
`specifically shows Prima Facie evidence that Insight has abandoned the ASPERGUM®
`
`trademark with no plans to resume use. A copy is hereby attached as Exhibit K.
`
`13. Pursuant to 37 CFR 2.120(j)(3)(i), Petitioner Jeffiey Kaplan (“Kaplan”) hereby
`
`introduces into evidence Registrant’s Insight Pharmaceutical LLC (“Insight”) First Set of
`
`of Requests For Production of Documents and Things to Registrant and Responses Thereto,
`
`dated March 24'!‘ 2011 specifically Sales and Refimds ofASPERGUM® products for the year
`
`2007. The document is relevant on the issues of abandonment with no intent to resume use and
`
`specifically shows Prima Facie evidence that Insight has abandoned the ASPERGUM®
`
`trademark with no plans to resmne use. A copy is hereby attached as Exhibit L.
`
`14. Pursuant to 37 CFR 2.120(j)(3)(i), Petitioner Jefliey Kaplan (“Kaplan”) hereby
`
`introduces into evidence Registrant’s Insight Pharmaceutical LLC (“Insight”) First Set of
`
`of Requests For Production of Documents and Things to Registrant and Responses Thereto,
`
`dated March 24"‘ 2011 specifically Sales and Refimds of ASPERGUM® products for the year
`
`2008. The document is relevant on the issues of abandonment with no intent to resume use and
`
`specifically shows Prima Facie evidence that Insight has abandoned the ASPERGUM®
`
`trademark with no plans to resume use. A copy is hereby attached as Exhibit M.
`
`15. Pursuant to 37 CFR 2.120(i)(3)(i), Petitioner Jeffrey Kaplan (“Kaplan”) hereby
`
`introduces into evidence Registrant’s Insight Pharmaceutical LLC (“Insigh ”) First Set of
`
`of Requests For Production of Documents and Things to Registrant and Responses Thereto,
`
`dated March 24"‘ 2011 specifically Sales and Refunds of ASPERGUM® products for the year
`
`2009. The document is relevant on the issues of abandonment with no intent to resume use and
`
`specifically shows Prima Facie evidence that Insight has abandoned the ASPERGUM®
`
`trademark with no plans to resume use. A copy is hereby attached as Exhibit N.
`
`5
`
`
`
`16. Pursuant to TBMP 704.08(b) and 37 CFR § 2.122(e). regarding downloaded and
`
`printed intemet materials Kaplan hereby introduces into evidence a www.register.com web page
`
`from Whois dated June 8"‘ 2011 which indicates that Kaplan owns the domain address
`
`wvvwasperggmcom. The document is relevant on the issues of bona fide intent to use the
`
`trademark ASPERGUM when Kaplan filed his ITU Application with the USPTO. A copy is
`
`hereby attached as Exhibit P.
`
`Respectfiilly submitted,
`
`47>?
`
`2-6-12
`
`CERTIFICATE OF MAILING
`
`It is hereby certified that this document is being deposited First Class Postage Prepaid with the
`
`U.S. Postal Service addressed to Baker, Donelson, Bearman, Caldwell & Berkowitz, P.C. Att:
`
`Mr. Samuel Miller- 211 Commerce Street Suite # 800 Nashville, TN 37201.
`
`JetfieyKaplan
`
`2/6/12
`
`;
`
`
`
`
`
`EXHIBIT AEXHIBIT A
`
`
`
`r®“'tgfl fitfitkfi Bf angel.
`ff‘?
`
`mum States iaattut anh Eralmuark cbftite
`
`PUSS' N BOOTS
`
`Reg. No. 4,089,070
`
`JEFFREY KAPLAN (UNITED STATES INDIVIDUAL)
`POB 11 106
`
`Registered Jan. 17, 2012 FORT LAUDERDALE, FL 33339
`FOR: CAT FOOD, IN CLASS 31 (U.S. CLS. 1 AND 46).
`
`Int. Cl.: 31
`
`TRADEMARK
`
`PRINCIPAL REGISTER
`
`FIRST USE 1 1-24-201 1; IN COMIVIERCE 11-24-2011.’
`
`THE MARK CONSISTS OF STANDARD CHARACTERS WITHOUT CLAIM TO ANY PAR-
`TICULAR FONT, STYLE, SIZE, OR COLOR.
`
`SN 85-269,420, FILED 3-17-2011.
`
`JORDAN BAKER, EXAMINING ATTORNEY
`
`
`
`Dim:m1ofl.lxUl|iIndSm:sPntanmdTndam:k0ITu:e
`
`
`
`wfivmn étatez of Elmer’,
`muitzh fitates fiatent auh fltrahenwrk ®tfi£e
`
`TEGRIN
`
`Reg_ No.
`
`KAPLAN, JEFFREY (UNITED STATES INDIVIDUAL)
`POB 11106
`Registered Jan. 3, 2012 FORT LAUDERDALE. FL 33339
`
`Int. CL: 5
`
`FOR: MEDICATED SHAMPOO, 1N CLASS 5 (U.S. CLS. 6. 18.44.46, 51 AND 52).
`
`TRADEMARK
`
`PRINCIPAL REGISTER
`
`THE MARK CONSISTS o1= STANDARD CHARACTERS WITHOUT CLAIM TO ANY PAR-
`TICULAR FONT, STYLE, SIZE, OR couoR.
`
`FIRST use 11—1-2o1 1; IN COMMERCE 11-1-2011.
`
`SN 85-268.063. FIMSD 3-I6-2011.
`
`JORDAN BAKER, EXAMINING ATTORNEY
`
`
`
`Dilcclor unhc Uni1cd Slates Pnxcm and Trademark Offiu:
`
`
`
`®a“'m>jg étates of 211,121.,
`flatten flutes fiatent mm Qlitahemark ®tfixe
`
`HA1 KARATE
`
`JEFFREY KAPLAN (UNITED STATES INDIVIDUAL)
`Reg, No, 4,010,208
`POB 11106
`Registered Aug. 9, 2011 F1‘ LAUDERDALE. FL 33339
`Int. Cl.: 3
`FOR: AFTERSHAVE COLOGNE, IN CLASS 3 (U.s. c1.s. 1, 4, 6, so, 51 AND 52).
`
`TRADEMARK
`
`PRINCIPAL REGISTER
`
`THE MARK CONSISTS OF STANDARD CHARACTERS WITHOUT CLAIM TO ANY PAR-
`TICULAR FONT, STYLE, SIZE, on COLOR.
`
`FIRST USE 5-1-2011; IN COMMERCE 5-1-2011.
`
`sN 85-028.055, FILED 5-1-2010.
`
`JILL PRATER, EXAMINING ATTORNEY
`
`
`
`OM 5‘. KW»
`
`Dircclor oflhe United States Pan-.m and Tnzdcnuu-k Ofiice
`
`
`
`wmmn étates of am1‘ I
`flatten Qtates Bateut mm Eralmuark ®ftt’:2
`
`
`
`Il%sll;Ii1i\:~I0,6JI1‘FREY (UNITED STATES INDIVIDUAL)
`Reg. No. 4,044,298
`Registered Oct. 25, 2011 FT. LAUDERDALE, FL 33339
`
`Int. Cl.: 25
`
`FOR: T-SHIRTS, IN CLASS 25 (U.S. CLS. 22 AND 39).
`
`TRADEMARK
`
`PRINCIPAL REGISTER
`
`FIRST USE 1-1-2011; IN COMMERCE 1-1-2011.
`
`THE MARK CONSISTS o1= TI-IEWORDING “HA1 KARATE" INAN ORIENTAL FONTWITH
`Two HANDS SURROUNDING THE WORDS INA KARATE CHOP POSE. AT THE BOTTOM
`or THE MARK IS THE WORDING "AFTER SHAVE".
`
`SER. No. 85-239,675, FILED 2-11-2011.
`
`JORDAN BAKER, EXAMINING ATTORNEY
`
`
`
`Director oflhe United Slmes Palm! :1nd'l'r:1d:Imrk (Mic:
`
`
`
`
`
`,1} :5’ 3'; ‘r-* I’ Jar-'r:;g:
`fin‘ J re"f':.z W ‘fie
`
`http://tdrweb.uspto.gov/ts/cd/casedoc/sn854213 84/PST20l2013 1023 555/2/webcontent
`
`2/3/2012
`
`
`
`
`__
`
`-.
`
`..-w -
`
`_-..
`
`
`
`
`Trademark Snap Shot Publication Stylesheet
`(Table presents the data on Publication Approval)
`
`OVERVIEW
`
`SERIAL NUMBER
`
`REG NUMBER
`
`REGISTER
`
`INTL REG #
`
`85421384
`
`III
`
`PRINCIPAL
`
`FILING DATE
`
`REG DATE
`
`MARK TYPE
`
`09/13/2011
`
`N/A
`
`TRADEMARK
`
`NIA
`
`INTL REG DATE
`
`TM ATTORNEY
`
`SHOSHO II, ERNEST
`
`L.O. ASSIGNED
`
`M80-NOT FOUND
`
`PUB INFORMATION
`
`RUN DATE
`
`PUB DATE
`
`STATUS
`
`N/A
`
`680-APPROVED FOR PUBLICATON
`
`STATUS DATE
`
`01/28/2012
`
`LITERAL MARK ELEMENT
`
`IT'S HERE! THE ORIGINAL CHIPVVICH CHOCOLATE CHIP COOKIE ICE CREAM
`SANDWICH
`
`DATE ABANDONED
`
`SECTION 2F
`
`SECTION 8
`
`SECTION 15
`
`DATE AMEND REG
`
` RENEWAL FILED
`
`
`
`FILED BASIS
`
`1 (a)
`
`1 (b)
`
`DATE CANCELLED
`
`SECTION 2F IN PART
`
`SECTION 8 IN PART
`
`REPUB 12C
`
`RENEWAL DATE
`
`N/A
`
`N/A
`
`N/A
`
`N/A
`
`FILING BASIS
`
`CURRENT BASIS
`
`AMENDED BASIS
`
`Y S
`
`1 (8)
`
`1 (b)
`
`YES
`
`1 (a)
`
`1 (b)
`
`
`
`
`NO BASIS
`
`66A
`
`NO BASIS
`
`
`
`http://tdrweb.uspto.gov/ts/cd/casedoc/sn854213 84/PST2012013 1023 5 5 5/1 /webcontent
`
`2/3/2012
`
`
`
`STANDARD CHARACTER MARK
`
`LITERAL MARK ELEMENT
`
`MARK DRAWING CODE
`
`IT'S HERE! THE ORIGINAL CHIPVVICH CHOCOLATE
`CHIP COOKIE ICE CREAM SANDWICH
`
`3-AN ILLUSTRATION DRAWING vvI-IIcH INCLUDES
`WORD(S)lLETTER(S)INUMBER(S)
`
`COLOR DRAWING FLAG
`
`YES
`
`CURRENT OWNER INFORMATION
`
`PARTY TYPE
`
`ADDRESS
`
`ENTITY
`
`CITIZENSHIP
`
`INTERNATIONAL CIASS
`
`DESCRIPTION TEXT
`
`10-ORIGINAL APPLICANT
`
`Kaplan, Jeffrey
`
`POB 11106
`Fort Lauderdale, FL 33339
`
`O1-INDIVIDUAL
`
`United States of America
`
`GOODS AND SERVICES
`
`GOODS AND SERVICES CLASSIFICATION
`
`INTERNATIONAL
`CLASS
`
`FIRST USE
`DATE
`
`06/01/2011
`
`FIRST USE
`IN
`COMMERCE
`DATE
`
`06/01/2011
`
`CLASS
`STATUS
`
`6-ACTIVE
`
`MISCELLANEOUS INFORMATION/STATEMENTS
`
`CHANGE IN REGISTRATION
`
`COLORS CLAIMED STATEMENT
`
`DESCRIPTION OF MARK
`
`The coIor(s) white, red, light brown, reddish brown and dark
`brown is/are claimed as a feature of the mark.
`
`The mark consists of the words It's here! in white letters on a
`red banner along with the words The Original Chipwich
`Chocolate Chip Cookie Ice Cream Sandiwch in dark brown
`letters along with an image of a partially eaten ice cream
`cookie sandwich with chocolate chips with the colors of
`white, light brown and dark brown all placed on a circular
`background with reddish brown tones.
`
`http://tdrweb.uspto.gov/ts/cd/casedoc/sn85421 3 84/PST2012013 1023555/1/webcontent
`
`2/3/2012
`
`
`
`PSEUDO MARK
`
`IT IS HERE! THE ORIGINAL CHIP SANDWICH
`CHOCOLATE CHIP COOKIE ICE CREAM SANDWICH
`
`OWNER OFUSREGNOS
`
`PROSECUTION HISTORY
`
`DATE
`
`ENT CD
`
`ENT
`TYPE
`
`DESCRIPTION
`
`ENT NUM
`
`01/28/2012
`
`01/25/2012
`
`01/25/2012
`
`12/29/201 1
`
`12/29/201 1
`
`12/29/201 1
`
`09/17/201 1
`
`09/16/201 1
`
`09/1 6/201 1
`
`CNSA
`
`HI
`
`APPROVED FOR PUB - PRINCIPAL REGISTER
`
`TEAS/EMAIL CORRESPONDENCE ENTERED
`
`CORRESPONDENCE RECEIVED IN LAW OFFICE
`
`TEAS RESPONSE TO OFFICE ACTION RECEIVED
`
`NOTIFICATION OF NON-FINAL ACTION E-MAILED
`
`F
`
`NON-FINAL ACTION E-MAILED
`
`NON-FINAL ACTION WRITTEN
`
`ASSIGNED TO EXAMINER
`
`NOTICE OF DESIGN SEARCH CODE AND PSEUDO
`MARK MAILED
`
`NWOS
`
`NWAP
`
`NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
`IN TRAM
`
`III
`III
`I III
`II
`I I
`NEW APPLICATION EN ERED IN TRAM
`
`I II I I I
`
`I~1 I
`
`CURRENT CORRESPONDENCE INFORMATION
`
`*“"°R"EY
`CORRESPONDENCE ADDRESS
`JEFFREY KAPLAN
`PO BOX 1 1 106
`FORT LAUDERDALE, FL 33339-1106
`
`http://tdrweb.uspto.gov/ts/cd/casedoc/sn85421 3 84/PST201201 3 1 02355 5/1 /webcontent
`
`2/3/2012
`
`
`
`,®“'m>.‘n %tate§ of aweF I
`- mniteh §tat2$ fiatent auh flfirahzmark ®fft'te
`
`DI-GEL
`
`Reg. N0. 4,029,805
`
`JEFFREY KAPLAN (UNITED STATES INDIVIDUAL)
`POB 11106
`Registered Sep. 20, 2011 F1‘. LAUDERDALE, FL 33339
`
`Int. Cl.: 5
`
`FOR: ANTACIDS, IN CLASS 5 (us. CLS. 6, 18, 44,46, 51 AND 52).
`
`TRADEMARK
`
`PRINCIPAL REGISTER
`
`THE MARK CONSISTS OF STANDARD CHARACTERS WITHOUT CLAIM TO ANY PAR-
`'I'lCULAR FONT, STYLE. SIZE, OR COLOR.
`
`FIRST USE 7-I-2011; IN COMMERCE 7-I-2'01 I.
`
`SN 85-107,811. FILED 8-15-2010.
`
`MELISSA VALLILLO, EXAMINING ATTORNEY
`
`
`
`QM E KW
`
`Director ufuxe United Sums PaI.cnt and Trademark Ollie:
`
`
`
`
`
`Reg ;\'n_ 4,062_,|33
`
`kAPl.A.\. .n.mu-.v um: |‘I1DS-‘la-U 1-.5 I~4uI\-Ims;u.,.
`rm: mix»
`
`Regnstered how. 29, 20! I 1''!’ I..-1.T.'DERDALE.FL3.‘~3J£-
`
`Inl. CI.: 30
`
`mu m‘ r.Rr..-\M_1\'r-I ass an-ms «'1. 4.1:.
`
`I‘R.-‘\l)|-Il\'l.4.RK
`
`I-‘IRST um-2 s-|.:m;r, |\ <:m-n.n-um-: S-I-2m-:1.
`
`PHINCIPA I.. Iu-'.GI.‘5‘I'I-'.R
`
`'llll.MA1-UL cmsms or ‘lllh -.-xomunu "(.'lllPwlf.'l|" IN mmu-.~. v.-mow1|n1:ANu
`u1u.w.':~x UL 1‘L.‘NL‘..\‘.
`
`Tnr :*r:n':ms:. rn-«awn .-\.\‘TH‘."1T‘:T'l'-. rsmzr r.r..-m-rrrn A s .-x F11:\T!TRT' nr 1-rm MARK
`
`rm: No. RS-MI,-:).‘~";.i*?l.l~|75-36-21110.
`
`AI .h.X Kl-..-\.\'l. kXA.\1|.\L\I'.i .-\'|'l'lJRI'- I-.‘.'
`
`
`
`'m'*I"tul"r.I.nnn! \u1- |'.r'*I'lr'I-1.1.-n~l!'I -II.':.
`
`http://tdrweb.uspto.gov/ts/cd/casedoc/sn8505 1 032/ORC201 1 1 1 29004824/1 /webcontent
`
`1/ 1 8/2012
`
`
`
`wfiitgb fitflttfi Of gmel.
`mutter: Qtatzs Bateut auh flttaheutark Gftitz
`
`DATRIL
`
`Reg. No_
`
`KAPLAN, JEFFREY (UNITED STATES INDIVIDUAL)
`POB 11106
`
`Registered Aug. 9, 2011 FT. LAUDERDALE, FL 33339
`
`Int. C1,: 5
`
`FOR: ANALGESICS, IN CLASS 5 (us. CLS. 5, 18, 44, 45, 51 AND 52).
`
`TRADEMARK
`
`FIRST USE 6-1-2011; IN COMMERCE 5-1-2011.
`
`PRINCIPAL REGISTER
`
`THE MARK CONSISTS OF STANDARD CHARACTERS WITHOUT CLAIM TO ANY PAR-
`TICULAR FONT, STYLE, SIZE, OR COLOR
`
`SN 85-050,676, FILED 5-23-2010.
`
`ALEX KEAM, EXAMINING ATTORNEY
`
`
`
`Dim¢mrofl.h:UniIedSm:sPnnmIuIdTndu.mrk0lfise
`
`
`
`wfiitgh Qtates Of @1113I‘ .
`Einitzh firms iiatmt aull Erahunarfi ®ffiI:c
`
`MAVI POWER
`
`imnrr-tn ST:'J.‘.S T.‘~lTJWll')TI.-’sI.'_I
`Reg_ _\ n, 3,871 ,053
`Registered Nut’. 2, 2010 H 1_».I.'1u.'1zmL1L Fl. 35339
`
`Int. CL: 32
`
`mu: |°.Nl-Zlv'.('-'1’ m<n~u<:~: (‘K 1\ I2-'-. Nwu rs.-‘.>w1 ax‘: IL-"'.r.Z‘l
`M :--15¢;
`
`l\. truxss 32
`
`t:
`
`-15, +3
`
`T RADEM :1 RK
`
`TTRST I731’. ?-I -3;’: I-LI: L\' C'J?\i[MI-.’.1(.'T-I '.’-| -.''.\'.| I-1|.
`
`PRINCIPM. REC ISTER
`
`T111.’ Iv1.‘.3.K C024$813 L31 S1.-'L‘{l}:'\RD C11.-‘.l{:1(.T.ER5 13-‘11'110LT L"_:‘d.!s'l II’) .-’:N'[ .l’.-"sR-
`'l'1L"JL.*.3. I'll-N'_'_ STYLE.
`OR (‘OL0l
`
`Nil('.|.;'\Ifv1|I‘i \'1-'\lJl'. I'll ‘I HF l-'XL'l..|.‘{lV|>. l{|[iH'| ‘I0 LXI-' "M:‘.\" '. -‘\|'.-“. U HROK-1 FHE
`MEMIK -$53 SIN J'.’u'l'~.
`
`SN
`
`56,2 38, TETTIJ I-lii-HY.-9
`
`M.-"'J..K 8L'J.Nl.£'.L 1;'X:‘sH.lN.l.\' ' :"£l'lOR21E‘1'
`
`
`
`http://tdrweb.uspto.gov/ts/cd/casedoc/sn7765623 8/ORC20 1 01 1 02002245/1/webcontent
`
`1/ 1 8/2012
`
`
`
`fwmmn gtatez of gum1‘ .
`Giniteb 9131125 illattnt aub filrahmarfi ®ffiu:
`
`TEPACHE POWER
`
`E':,fiJ'lTJ'l-'11!’-.‘:' iUNTl'F|'} :11.-.125 T.‘Il'.IWlT)CI.-’sI.'_I
`Reg 5. n_ 3‘354,453
`Registered Sep. 28, 2010 1'1'L.:‘.|.'DL'RD.-’xLl£. 1-1 3333::
`
`Int. CL: 3?.
`
`I-OR: I-'\.~lt(i‘r' mewncs (.‘(1N'I-U‘. N<‘r‘IFl-l"-(L!-IH xx‘: Ia.-‘~<:I, I‘. cl,-\.~z:~: 32 (nus. US. -15,
`-1|’: .-"\'\|> 13;.
`
`TRADEMARK
`
`rust USE ?-|
`
`I-fr. r.\' cum.-tr-..':c1=. ?-ll-1|.
`
`l‘RINClPM. REC ISTER
`
`‘nu; 1»-14.31; consxsna Lu sm:~.1>A1uJ c1L«-.1<;.c‘1;'1<:= u'11'110I."1' L“_.-xus-1 :0 ANY mk-
`
`'l'1L"JL‘.3. l'l.‘rN‘.'. 9'1"YL1'.. &_._L'' " '. OR CQL03.
`
`NIIJ L'I-Al'\-1 IS '1-1-‘U1!-. '|() 'lH|-' I-.Xl.'.|.I.S \.-'H HGH I’ ' '0 USN. "' ‘I-‘I’.-".(‘.l-ll-Z", ;'\|#“. I‘ ' FROM
`'I III‘. \1.fi.RK.-"\.‘§ 5! K1‘.-\''\.
`
`SN 3'7-I-I 55,2 '.’5, I'E.TIl’J I-lfi-'.EI.‘f.-9
`
`M.-‘.3.K SIJNILL 1;'X:‘aMlNL‘lU :"L1‘l01L‘~l.|;"1'
`
`
`
`\r'1Vul“- I lI'|l‘ V13-I'|"ff‘fl' I !.I"I-fil 171:1.
`
`http://tdrweb.uspto.gov/ts/cd/casedoc/sn77656275/ORC201009280021 53/ 1/webcontent
`
`1/1 8/2012
`
`
`
`',®'“'“_gt| §>I&tB§ Of @1113r .
`fliniteh Qiates’ i3in:n1t aub Erahetnark tlfiffinr
`
`MR. Q. SPARKLING GIN
`
`‘.:IrI;'.I-‘F11!’-.‘:’iUNl‘l1?l'J8Tr'.'EST?~Il')TVll')ZI.’sI.'g
`Reg _\n_ 3,891,044
`Registered Dec. 14, 2010 IT L.-‘.|.'DL'RlJ:‘sL1L. 11 ssm
`
`lnl. CL: 33
`
`mu: s-vmrI.\', N ¢'|..-.s~;.:.'~n...~;. ms. -11-'.-\.Nn4-:2.
`
`TRADEMARK
`
`PRTNCTPIU. REC TSTER
`
`n mm vs»: nu- .2L:w;. l.\ L:ur.a:»1:;uc|-: um-2-zmz.
`
`‘III M.’C‘.K C02‘-TflSTS I211’ S-'1'.-‘L\'[lARD C11.-*.RACIZl'¢.$ ‘FtTI'IIII'T.T C‘L:‘.B-'1 ".33 .-’xN'}" P.-'\.R-
`'IlL"JL‘.l 1’L‘IN‘.L 8'IYL.l:.
`OR COLOR.
`
`N-."l (‘1..-UM IS M-‘KY-' TO 'I H‘-' I-fk[‘l.l HIVH li|(H~"l' T0 l.‘.‘iF.
`I-R(II'\-1 |'H|-I ":1.-'\It'~'. :‘..‘i.‘IH( J‘.’b'k.
`
`'S|’.fi.|Zk'IJN(i- l'¥|N"_ -"\F!\R'|'
`
`SN .-":'-8Il|,':H|,I |..|-"J3 K-2'.‘-Ell-U
`
`M:‘L'{GIII{'.‘.' A. '1']]ER1\'E§:'. ER';\.l‘.$lNDI!Ii ;"J'1'I3l'<NEY
`
`
`
`\I~"1*v«-P". I Inn‘ ~r.'I- I'|"nInI' I !.I*'I~(rI flan.
`
`http://tdrweb.uspto.gov/ts/cd/casedoc/sn77810710/ORC2010l2140041 06/1/webcontent
`
`1/1 8/2012
`
`
`
`(®“"{g]] gtateg of am?r .
`Elniteh étates’ iiiatntt auh Ufirabmuark ®ffiaz
`
`MR. Q. CUMBER
`
`Is'..‘\T'L-‘.\', JtrrR1'-.'»'(IINn1?r;sTr.r.s T.‘-Il'.IWIl)'.I.-’vI.'_I
`Reg, _\.1, 3,849,496
`r—.-::.B.
`.1u:v:~
`_
`.
`Regxstered Sep. 21, 2010 ls')R.1"_.-\|.|DL'.[L"J!u.1;'. 1'1. 3333.»
`
`Int. CL: 32
`
`I-(Jli:NiN-I\.l.(?(>H<)H(2 I-2-\"l~.lt!\tH-I\1,f~.:\M-l.$,£Ir\liH(l\Nl -|JHH~.'FI<.-mr~:a. NtII..-15$
`12 .jI..s. «:15. -I5 'I::.-‘.\I|) -Isa:-.
`
`IRA DE MA RK
`
`TEST USF. "- -’.9.'.Il‘..‘-: T.\' C'3M'f'.’T|?1CT-3 2-I -2:’,IC.1.
`
`PRINCIPAT. REC ISTER
`
`‘I111.’ M.’L!.K CON ‘.1l.‘31‘.‘ L71 5'1.-‘\.\l.}.*LR.I.) C11.-*.R:'sCT'_'R3 V-‘11'1l0L'1' L‘Z.:\lM '.'\') .-'xN1' 1’.-'\R-
`
`'flL"Jl...".3. l'L}N'_' S'l'Y1J.'.. h_._L''7 '. OR COLOR.
`
`HI-IN. Nil. ‘T-‘-Hlilfl-'13, ‘ L-I) .‘!-22-2IZIIF'.
`
`MA.-{£i|'.R':' A. "I II-I|¢'.M.E', |€X.°J~‘2lN|N{i.-‘-l'I[)l{N|{'f
`
`
`
`\t~-11.-I--. I n-ur V'.'I-I‘I"fl'lH'
`
`I :.I--uvrn -um.
`
`http://tdrweb.uspto.gov/ts/cd/casedoc/sn778 1071 3/ORC20100921004756/1/webcontent
`
`1/1 8/2012
`
`
`
`“mu fitates of gumr .
`Elniteb flute! iliattlltauh fllralmltarh @101:
`
`SPARKLING COW
`
`Reg _\ n_ 3,800,335
`
`rm:-:..-..\*, JITI-'17]-‘II’-.‘:’ir'J.)'$.-.NIr'\ mrm1m:..vu.;.
`my u.-25
`
`Registered June 8, 2010 11' L-‘.|.'Dl.'RD:'.Ll; 11 33-339
`
`Int. CL: 32.
`
`wk: N-IN-Al.(.‘(>H¢)I.ItI H-x-1-.R.-\m r«.-1»1-n.==,::M-:H<1\..-u -n HH.\.'Fli;‘\li-I-IF-. m:I..-..~'.~z
`12 9.5. ms. 15 -u:..-4.\u) -Is:-.
`
`T RA DEMARK
`
`I'T."».$T USE 2-! -3! I-.'.I: Bx" C'.‘|3«/[MT-_"{(.'I"3 2-
`
`I-1|.
`
`PRINCIPAT. REC TSTER
`
`T111.‘ LMRK C0_‘45l8'1‘.$ L71 S1.-"n.‘il.}A.R.D C11.-'-.R:‘;CT_.'R$ \-?l1'll0LT L‘.'..-"L15-‘1'..U .-‘:.N Y PAR-
`'l'lL"JL.‘.1l'L‘IN'_'. ST‘!L19.
`OR COLOR.
`
`Nil(..'|..-U\1l."- \‘1-'\l)F.'l()'|HF I-.X(II.l.K '\-‘I-. RIGH I" '0 |..‘iF '5 ‘.-‘KRKJ. NC-"._-‘\|".-‘\|t'| H'lt()M
`'l‘:l||'-\1-‘ERK .-"'-."~ 5| |¢]‘A"\.
`
`an 77.s.~—',3sI,r1:.r.r: .1..‘.n-2v:r..-s
`
`Jl.'I~'.\I1-LR VA80_L'1:”.’. LN.-'\.\flS3~'G .*J'F."RNl.'.\‘
`
`
`
`\r-1-vnfw I n'\-' N-.\-l'I"vr<Ir I :.|--I-rn -um.
`
`http://tdrweb.uspto.gov/ts/cd/casedoc/sn7753435 1/ORC20100608003058/1/webcontent
`
`1/1 8/2012
`
`
`
`
`
`EXHIBIT BEXHIBIT B
`
`
`
`IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`TRADEMARK TRIAL AND APPEAL BOARD
`
`
`JEFFREY KAPLAN,
`
`Petitioner,
`
`v.
`
`INSIGHT PHARMACEUTICALS, LLC
`
`Registrant.
`
`\J\f%\fi§J\i€€%€%
`
`Cancellation No. 92053030
`
`Registration No. 792,115
`
`
`
`INSIGHT PHARMACEUTICALS, LLC'S RESPONSES TO PETITIONER'S
`FIRST SET OF WRITTEN INTERROGATORIES T0 REGISTRANT
`
`COME NOW Registrant Insight Pharmaceuticals, LLC ("lnsight" or "Registrant"), by
`
`and through its undersigned counsel, Samuel F. Miller and Micheline Kelly Johnson of Baker,
`
`Donelson, Bearman, Caldwell and Berkowitz, P.C., and hereby responds to Petitioner Jeffrey
`
`Kaplan's ("Kaplan") First Set of Written Interrogatories to Registrant.
`
`GENERAL OBJECTIONS
`
`1.
`
`Insight’s responses and objections are made solely for the purpose of this action.
`
`Each response is subject to all objections as to competence, relevance, materiality, propriety and
`
`admissibility, and any and all other objections and grounds that would require the exclusion of
`
`any statement contained herein if made by any witness present and testifying in court or
`
`arbitration. All such objections and grounds are reserved and may be interposed at the time of
`
`trial or arbitration.
`
`2.
`
`The following responses are based upon infonnation presently available to Insight
`
`based upon a reasonably diligent investigation. Except for explicit facts admitted herein, no
`
`N SFM 812386 V3
`29l 8064-000003 03/24/2011
`
`l
`
`
`
`incidental or implied admissions are intended hereby. The fact that Insight has answered all or
`
`part of any interrogatory is not intended and shall not be construed to be a waiver of any
`
`objection to any interrogatory.
`
`Insight reserves the right
`
`to supplement or modify these
`
`responses based upon the discovery of additional or different information.
`
`3.
`
`Insight objects to the extent that the interrogatories seek to impose duties or
`
`requirements in addition to any requirements imposed by the Federal Rules of Civil Procedure,
`
`including, but not limited to, any instructions for answering. By answering these interrogatories,
`
`Insight does not agree to abide by any such additional instructions or requirements.
`
`4.
`
`5.
`
`Insight objects to Kaplan’s "Definitions" section in its entirety.
`
`Insight objects to any interrogatory to the extent that it seeks information and/or
`
`documents protected by the attomey-client privilege and/or the work product doctrine.
`
`6.
`
`Insight objects to these interrogatories in their entirety to the extent that they seek
`
`infonnation and/or documents not in the possession, custody, or control of Insight on the grounds
`
`that such interrogatories are overly broad and unduly burdensome, and constitute annoyance,
`
`harassment, and oppression.
`
`7.
`
`Insight conducted the search for infonnation and documentation in connection
`
`with Petitioner's First Set of Written Interrogatories with the necessary degree of diligence to
`
`locate responsive information and documents,
`
`in locations where responsive documents are
`
`likely to exist.
`
`N SFM 8|2386 V3
`29l 8064-000003 03/24/20l I
`
`
`
`RESPONSES TO INTERROGATORIES
`
`Subject to and without waiving its General Objections, Registrant provides the following
`
`responses:
`
`1.
`
`Identify the person or persons who created the name ASPERGUM.
`
`RESPONSE NO. 1:
`
`Insight objects to this Interrogatory as seeking information that is
`
`neither relevant nor likely to lead to the discovery of admissible evidence. The identity of the
`
`person or persons that created the trademark ASPERGUM has absolutely no bearing on issue in
`
`this case. The U.S. Registration for ASPERGUM is valid and incontestable.
`
`2.
`Identify the date and from whom if applicable, Registrant acquired the trademark
`rights to ASPERGUM.
`.
`
`RESPONSE NO. 2:
`
`Insight objects to this Interrogatory as seeking information that is
`
`neither relevant nor likely to lead to the discovery of admissible evidence. The date Registrant
`
`acquired the trademark rights is not relevant to any issue in this case. Further such information is
`
`readily available to Kaplan from public domain sources — namely, the USPTO website.
`
`3.
`
`Identify the total number of units or cases by year that were manufactured and/or
`
`co-packed for and sold by Registrant that used the mark ASPERGUM for the following years:
`
`2006, 2007, 2008, 2009 and 2010 in interstate commerce.
`
`RESPONSE NO. 3:
`
`Insight objects to this Interrogatory as overly broad, unduly
`
`burdensome, and seeking information that is neither relevant not likely to lead to the discovery
`
`of admissible evidence. Further, Insight objects to this lnterrogatory as vague and ambiguous in
`
`its use of the word “co-packed." Subject to and without waiving any of its general or specific
`
`N SFM M2386 V3
`2918064-000003 03/24/20l l
`
`
`
`objections, and pursuant to Fed. R. Civ. P. 33(d), Registrant attaches hereto as Exhibit A
`
`business records showing its sales and credits for the years 2005 through 2010.
`
`4.
`
`In regard to each item identified in your response to Interrogatory 3 state:
`
`a.
`
`The wholesale dollars valuation of total sales by each year.
`
`RESPONSE N0. 4: Registrant objects to this Interrogatory as vague, ambiguous, overly
`
`broad, unduly burdensome, and seeking infonnation that is neither relevant not likely to lead to
`
`the discovery of admissible evidence. Further, Insight objects to this Interrogatory as vague and
`
`ambiguous based on its use of “wholesale dollars valuation." Subject to andlwithout waiving
`
`any of its general or specific objections, and pursuant to Fed. R. Civ. P. 33(d), Registrant
`
`attaches hereto as Exhibit A business records showing its sales and credits for the years 2005
`
`through 2010.
`
`5.
`
`Identify the person or persons employed by Registrant who had primary
`
`responsibility in the ongoing research, development and manufacturing of each of the products
`
`that used the mark ASPERGUM for the following years: 2006, 2007, 2008, 2009 and 2010.
`
`RESPONSE NO. 5:
`
`Insight objects to this lnterrogatory as vague, ambiguous, overly
`
`broad, unduly burdensome, and seeking infonnation that is neither relevant nor likely to lead to
`
`the discovery of admissible evidence.
`
`Subject to Registrant’s General Objections and the
`
`foregoing objections, Dennis Kinsey, who is employed by Registrant and may be contacted only
`
`through Registrant’s counsel.
`
`6.
`
`Identify those persons employed by Registrant who it reasonably believes to have
`
`N SFM 8l2386 v3
`29| 8064-000003 03/24/20! I
`
`4
`
`
`
`the most knowledge of the current and/or prospective sales, marketing, and channels of
`
`distribution of products sold under the mark ASPERGUM for the years 2006, 2007, 2008, 2009
`
`and 2010.
`
`RESPONSE NO. 6: Insight objects to this Interrogatory as overly broad. Subject to the
`
`foregoing and its General Objections, Insight states that Mike Tukdarian has information
`
`concerning the sales, marketing and channels of distribution for products sold under the
`
`ASPERGUM mark for the years 2006-2010.
`
`7.
`
`Identify the Registrant's internet web page that promotes or advertises their
`
`product named ASPERGUM to the general public that is in use in interstate commerce for the
`
`years: 2006, 2007, 2008, 2009 and 2010.
`
`RESPONSE N0. 7:
`
`Insight objects to this Interrogatory as vague, ambiguous, overly
`
`. broad, unduly burdensome, and seeking information that is neither relevant nor likely to lead to
`
`the discovery of admissible evidence. Subject to and without waiving any of its general or
`
`specific objections, Registrant states that it did maintain a web page on www.insightpharma.com,
`
`prior to October 2010, for promoting and advertising products bearing the mark ASPERGUM.
`
`8.
`
`Identify the Registrant's intemet web page and or URL address that informs the
`
`public that their product named ASPERGUM will be re—launched or re-introduced to the general
`
`public for the years: 2006, 2007, 2008, 2009 and 2010.
`
`Insight objects to this Interrogatory as vague, ambiguous, overly
`
`broad, unduly burdensome, and seeking information that is neither relevant nor likely to lead to
`
`the discovery of admissible evidence. Specifically, Insight objects to this intermgatory to the
`
`IN SFM 812386 v3
`2918064-000003 03/24/20! I
`
`
`
`extent it implies that the product ASPERGUM needs to be re-launched or re-introduced to the
`
`general public, or that Insight is required to inform the public of its confidential and proprietary
`
`marketing plans via a website or webpage.
`
`9.
`
`Identify any post cards, letters, mailers, advertisements. brochures or any type of
`
`Documents that has been or is being sent to the general public about the re-launch or re-
`
`introduction of the Registrant's product named ASPERGUM for the years: 2006, 2007, 2008,
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
